Bharat Parenterals Ltd
Bharat Parenterals Ltd Live Price Chart
Bharat Parenterals Ltd Technicals
| 20 Day | ₹ 1,037.524 |
| 50 Day | ₹ 1,109.070 |
| 100 Day | ₹ 1,164.894 |
| 200 Day | ₹ 1,213.599 |
| 20 Day | ₹ 1,065.610 |
| 50 Day | ₹ 1,128.217 |
| 100 Day | ₹ 1,175.816 |
| 200 Day | ₹ 1,232.766 |
Bharat Parenterals Ltd Performance
| Previous Close | ₹ 947.95 |
| High | ₹ 980 |
| Volume | 1186 |
| 52W Range | ₹ 802 - ₹ 1667.2 |
| Open | ₹ 947.3 |
| Low | ₹ 947 |
| Market Cap | ₹ 801 Cr |
Bharat Parenterals Ltd Fundamentals
| ROCE | 8.247 |
| P/E Ratio | 39.740 |
| P/B Ratio | 1.690 |
| Industry P/E | 1.690 |
| Debt to Equity | 39.451 |
| ROE | 5.393 |
| EPS | 24.550 |
| Dividend Yield | 0.100 |
| Book Value | 578.778 |
| Face Value | 10.000 |
Bharat Parenterals Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 318.682 | 266.114 | 236.8199 | 219.7916 | 212.3372 |
| Total Expenses | 282.3668 | 235.3131 | 204.6506 | 191.4232 | 185.3182 |
| Profit After Tax | 26.4536 | 22.5936 | 24.3369 | 21.3036 | 20.2105 |
Bharat Parenterals Ltd Shareholding Pattern
| Promoter Holdings | 67.194 % |
| FIIs | 0.109 % |
| DIIs | 0.542 % |
| MutualFund | 0.000 % |
| Retail | 19.215 % |
| Others - | 12.940 % |
About Bharat Parenterals Ltd
History of Bharat Parenterals Ltd
Bharat Parenterals Limited was incorporated in September, 1992 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company on 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective from 28th June, 2022. ...
